» Articles » PMID: 36797475

Stiff Matrix Induces Exosome Secretion to Promote Tumour Growth

Abstract

Tissue fibrosis and extracellular matrix (ECM) stiffening promote tumour progression. The mechanisms by which ECM regulates its contacting cells have been extensively studied. However, how stiffness influences intercellular communications in the microenvironment for tumour progression remains unknown. Here we report that stiff ECM stimulates the release of exosomes from cancer cells. We delineate a molecular pathway that links stiff ECM to activation of Akt, which in turn promotes GTP loading to Rab8 that drives exosome secretion. We further show that exosomes generated from cells grown on stiff ECM effectively promote tumour growth. Proteomic analysis revealed that the Notch signalling pathway is activated in cells treated with exosomes derived from tumour cells grown on stiff ECM, consistent with our gene expression analysis of liver tissues from patients. Our study reveals a molecular mechanism that regulates exosome secretion and provides insight into how mechanical properties of the ECM control the tumour microenvironment for tumour growth.

Citing Articles

Modes of Notch signalling in development and disease.

Bray S, Bigas A Nat Rev Mol Cell Biol. 2025; .

PMID: 40065190 DOI: 10.1038/s41580-025-00835-2.


COLEC10: A potential tumor suppressor and prognostic biomarker in hepatocellular carcinoma through modulation of EMT and PI3K-AKT pathways.

Ke R, Dai Y, Tu Y, Liu Z, Huang K, Zhang F Open Life Sci. 2025; 20(1):20220988.

PMID: 40026364 PMC: 11868708. DOI: 10.1515/biol-2022-0988.


Identification of blood-derived exosomal tumor RNA signatures as noninvasive diagnostic biomarkers for multi-cancer: a multi-phase, multi-center study.

Wang F, Wang C, Chen S, Wei C, Ji J, Liu Y Mol Cancer. 2025; 24(1):60.

PMID: 40025576 PMC: 11871737. DOI: 10.1186/s12943-025-02271-4.


A glucose-enriched lung pre-metastatic niche triggered by matrix stiffness-tuned exosomal miRNAs in hepatocellular carcinoma.

Zhao Y, Yu H, Li J, Qian J, Li M, Zhang X Nat Commun. 2025; 16(1):1736.

PMID: 39966385 PMC: 11836368. DOI: 10.1038/s41467-025-56878-8.


Extracellular vesicles in tumor immunity: mechanisms and novel insights.

Kuang L, Wu L, Li Y Mol Cancer. 2025; 24(1):45.

PMID: 39953480 PMC: 11829561. DOI: 10.1186/s12943-025-02233-w.


References
1.
Butcher D, Alliston T, Weaver V . A tense situation: forcing tumour progression. Nat Rev Cancer. 2009; 9(2):108-22. PMC: 2649117. DOI: 10.1038/nrc2544. View

2.
Broders-Bondon F, Nguyen Ho-Bouldoires T, Fernandez-Sanchez M, Farge E . Mechanotransduction in tumor progression: The dark side of the force. J Cell Biol. 2018; 217(5):1571-1587. PMC: 5940296. DOI: 10.1083/jcb.201701039. View

3.
Fattovich G, Stroffolini T, Zagni I, Donato F . Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004; 127(5 Suppl 1):S35-50. DOI: 10.1053/j.gastro.2004.09.014. View

4.
Laklai H, Miroshnikova Y, Pickup M, Collisson E, Kim G, Barrett A . Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Nat Med. 2016; 22(5):497-505. PMC: 4860133. DOI: 10.1038/nm.4082. View

5.
Levental K, Yu H, Kass L, Lakins J, Egeblad M, Erler J . Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906. PMC: 2788004. DOI: 10.1016/j.cell.2009.10.027. View